Revive Biotechnology Inc.

UEI
GR6BLT49FMG4
CAGE
87ZC9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
revivebiotech.com
Founded
2018
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Information Technology
  2. Technology Hardware & Equipment
  3. Electronic Equipment, Instruments & Components
  4. Nanotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Sttr phase II: intravitreal oxygen nanobubble technology for treatment of retinal artery occlusions 2236857 National Science Foundation $998,356
Sbir phase i: intravitreal oxygen nanobubble technology for treatment of retinal artery occlusions 2031313 Division of Industrial Innovation $256,000

Quick answers

Is Revive Biotechnology Inc. registered in SAM.gov?

Revive Biotechnology Inc.'s SAM.gov registration expired on March 14, 2026.

What is Revive Biotechnology Inc.'s most recent federal award?

Revive Biotechnology Inc.'s most recent federal grant award is Sttr phase II: intravitreal oxygen nanobubble technology for treatment of retinal artery occlusions (2236857), from National Science Foundation, on August 1, 2023.

On GovTribe

See Revive Biotechnology Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login